liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Karolinska Institute, Sweden; Karolinska University Hospital, Sweden.
Karolinska Institute, Sweden; Karolinska University Hospital, Sweden.
Karolinska Institute, Sweden; Karolinska University Hospital, Sweden.
Karolinska University Hospital, Sweden.
Show others and affiliations
2015 (English)In: Sarcoidosis Vasculitis and Diffuse Lung Diseases, ISSN 1124-0490, Vol. 32, no 1, 63-69 p.Article in journal (Refereed) Published
Abstract [en]

Background: Glucocorticoid induced osteoporosis is a well-known side effect of glucocorticoid treatment. In sarcoidosis the impact on bone by glucocorticoid treatment is complex due to hormonal disturbances of calcium and vitamin-D, which by itself may cause bone loss. In this study we aimed to investigate the longitudinal impact of glucocorticoids on cortical and trabecular bone in patients with mild, recently diagnosed sarcoidosis.

Methods: Ten patients (8 females; mean age 44 (+/- 13)) were studied during one year of glucocorticoid treatment. The assessment of mainly cortical to purely trabecular bone was made by dual X-ray absorptiometry (DXA) of the spine and hip, quantitative ultrasound of the calcaneus, and magnetic resonance relaxometry of the spine and calcaneus. Bone and hormonal measurements were performed at baseline, after 3, 6, and 12 months, and baseline, 3 weeks and 3 months, respectively.

Results: DXA of the spine, decreased from baseline at 6 months (P=0.01). R2 of the calcaneus decreased with time (B: -3.6; P=0.03). In the females (n=8) there was a significant decrease in DXA of the spine when comparing 3 months and 6 months (P=0.03), and 3 months and 12 months (P=0.02) and a decrease in R2 of the calcaneus from baseline to 12 months (P=0.01). There was no change in hormonal levels.

Conclusion: Treatment of initial mild sarcoidosis with dose tapered glucocorticoid therapy only mildly affects the final trabecular and cortical bone and hormone levels. Dose tapering is an important part in glucocorticoid therapy, likely contributing to the mild effects on bone observed in this study.

Place, publisher, year, edition, pages
MATTIOLI 1885 , 2015. Vol. 32, no 1, 63-69 p.
Keyword [en]
glucocorticoids; osteoporosis; sarcoidosis; DXA; MRI; relaxometry; ultrasound
National Category
Endocrinology and Diabetes
URN: urn:nbn:se:liu:diva-120759ISI: 000358614100007PubMedID: 26237357OAI: diva2:848154

Funding Agencies|Swedish Medical Research Council

Available from: 2015-08-24 Created: 2015-08-24 Last updated: 2015-09-15

Open Access in DiVA

No full text


Search in DiVA

By author/editor
Ringertz, Hans
By organisation
Division of Radiological SciencesFaculty of Health SciencesCenter for Medical Image Science and Visualization (CMIV)
In the same journal
Sarcoidosis Vasculitis and Diffuse Lung Diseases
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 39 hits
ReferencesLink to record
Permanent link

Direct link